EP3340966
Hraðverkandi insúlínsamsetningar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.8.2016EP published:
12.10.2022EP application number:
16771021.9
EP translation filed:
21.11.2022Grant published:
15.12.2022EPO information:
European Patent Register
Max expiry date:
18.8.2036Expiry date:
18.8.2026Next due date:
31.8.2026
Title in English:
RAPID-ACTING INSULIN COMPOSITIONSLanguage of the patent:
English
Timeline
Today
19.8.2016EP application
12.10.2022EP Publication
21.11.2022Translation submitted
15.12.2022Registration published
18.8.2026Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, Indianapolis, IN 46285, US
Inventor
Name:
AKERS, Michael PatrickAddress:
Indianapolis, Indiana 46206-6288, US
Name:
CHRISTE, Michael EdwardAddress:
Indianapolis, Indiana 46206-6288, US
Name:
HARDY, Thomas AndrewAddress:
Indianapolis, Indiana 46206-6288, US
Name:
MAJUMDAR, RanajoyAddress:
Indianapolis, Indiana 46206-6288, US
Name:
NGUYEN, Chi A.Address:
Indianapolis, Indiana 46206-6288, US
Name:
PAAVOLA, Chad D.Address:
Indianapolis, Indiana 46206-6288, US
Name:
SARIN, Virender KumarAddress:
Indianapolis, Indiana 46206-6288, US
Name:
SCHULTE, Nanette ElizabethAddress:
Indianapolis, Indiana 46206-6288, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562210469 PDate:
27.8.2015Country:
US
Classification
Categories:
A61K 9/00, A61K 38/28, A61K 47/02, A61K 47/12, A61K 47/10, A61K 31/192, A61P 3/10, A61K 47/34
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 20.7.2023
Expires: 18.8.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 23.7.2024
Expires: 18.8.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 12.8.2025
Expires: 18.8.2026
Payer: Árnason Faktor ehf.